{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:25:25Z","timestamp":1791141925636,"version":"4.1.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100011738","name":"Lee Kong Chian School of Medicine, Nanyang Technological University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001459","name":"Ministry of Education - Singapore","doi-asserted-by":"publisher","award":["RG 64\/12"],"award-info":[{"award-number":["RG 64\/12"]}],"id":[{"id":"10.13039\/501100001459","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.nano.2015.03.006","type":"journal-article","created":{"date-parts":[[2015,4,5]],"date-time":"2015-04-05T22:16:57Z","timestamp":1428272217000},"page":"1575-1584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["Stimuli-responsive liposomes for the delivery of nucleic acid therapeutics"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5554-2849","authenticated-orcid":false,"given":"Fatemeh","family":"Movahedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca G.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenjie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2015.03.006_bb0005","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.nano.2013.11.018","article-title":"Preclinical development of siRNA therapeutics: towards the match between fundamental science and engineered systems","volume":"10","author":"Videira","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2015.03.006_bb0010","series-title":"From Nucleic Acids Sequences to Molecular Medicine","first-page":"19","article-title":"Nucleic acids as therapeutics","author":"Pushpendra","year":"2012"},{"key":"10.1016\/j.nano.2015.03.006_bb0015","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.nano.2013.01.012","article-title":"Intelligent nanomaterials for medicine: carrier platforms and targeting strategies in the context of clinical application","volume":"9","author":"Lehner","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2015.03.006_bb0020","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.nano.2012.03.007","article-title":"Site directed vascular gene delivery in vivo by ultrasonic destruction of magnetic nanoparticle coated microbubbles","volume":"8","author":"Mannell","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2015.03.006_bb0025","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1021\/mp400467x","article-title":"Overcoming nonviral gene delivery barriers: perspective and future","volume":"10","author":"Jones","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nano.2015.03.006_bb0030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/2277-9175.98152","article-title":"Viral and nonviral delivery systems for gene delivery","volume":"1","author":"Nayerossadat","year":"2012","journal-title":"Adv Biomed Res"},{"key":"10.1016\/j.nano.2015.03.006_bb0035","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.nantod.2010.03.003","article-title":"Targeted nanodelivery of drugs and diagnostics","volume":"5","author":"Phillips","year":"2010","journal-title":"Nano Today"},{"key":"10.1016\/j.nano.2015.03.006_bb0040","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/IJN.S596","article-title":"Drug delivery and nanoparticles: applications and hazards","volume":"3","author":"De Jong","year":"2008","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2015.03.006_bb0045","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1164\/rccm.200504-613PP","article-title":"The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis","volume":"172","author":"Gelperina","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.nano.2015.03.006_bb0050","doi-asserted-by":"crossref","DOI":"10.1038\/srep02534","article-title":"Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization","volume":"3","author":"Gao","year":"2013","journal-title":"Sci Rep"},{"key":"10.1016\/j.nano.2015.03.006_bb0055","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/12_2011_129","article-title":"Delivery of Nucleic Acid Drugs","volume":"249","author":"Lee","year":"2012","journal-title":"Advances in Polymer Science"},{"key":"10.1016\/j.nano.2015.03.006_bb0060","first-page":"10","article-title":"Liposomes: a novel drug delivery system","volume":"3","author":"Kulkarni","year":"2011","journal-title":"Int J Curr Pharm Res"},{"key":"10.1016\/j.nano.2015.03.006_bb0065","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2119\/molmed.2009.00101","article-title":"Cellular endocytosis and gene delivery","volume":"16","author":"Ziello","year":"2010","journal-title":"Mol Med"},{"key":"10.1016\/j.nano.2015.03.006_bb0070","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1517\/17425247.2011.559223","article-title":"Recent advances of siRNA delivery by nanoparticles","volume":"8","author":"Yuan","year":"2011","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.nano.2015.03.006_bb0075","first-page":"111","article-title":"Factors affecting drug release from liposomes","volume":"13","author":"Lindner","year":"2010","journal-title":"Curr Opin Drug Discov Devel"},{"key":"10.1016\/j.nano.2015.03.006_bb0080","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-2836(65)80093-6","article-title":"Diffusion of univalent ions across the lamellae of swollen phospholipids","volume":"13","author":"Bangham","year":"1965","journal-title":"J Mol Biol"},{"key":"10.1016\/j.nano.2015.03.006_bb0085","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2217\/nnm.11.122","article-title":"Liposomes as drug delivery systems for the treatment of TB","volume":"6","author":"Pinheiro","year":"2011","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.nano.2015.03.006_bb0090","series-title":"Multifunctional Nanoparticles for Drug Delivery Applications","first-page":"9","article-title":"Nanoparticles for targeted and temporally controlled drug delivery","author":"Swami","year":"2012"},{"key":"10.1016\/j.nano.2015.03.006_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nano.2012.05.013","article-title":"The big picture on nanomedicine: the state of investigational and approved nanomedicine products","volume":"9","author":"Etheridge","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2015.03.006_bb0100","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1038\/mtna.2012.18","article-title":"Peptide-mediated cell and in vivo delivery of antisense oligonucleotides and siRNA","volume":"1","author":"Jarver","year":"2012","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.nano.2015.03.006_bb0105","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nmat3765","article-title":"Delivery materials for siRNA therapeutics","volume":"12","author":"Kanasty","year":"2013","journal-title":"Nat Mater"},{"key":"10.1016\/j.nano.2015.03.006_bb0110","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.addr.2009.04.018","article-title":"siRNA delivery systems for cancer treatment","volume":"61","author":"Oh","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2015.03.006_bb0115","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fphar.2014.00090","article-title":"Safety of liposome extended-release bupivacaine for postoperative pain control","volume":"5","author":"Portillo","year":"2014","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.nano.2015.03.006_bb0120","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2162-3619-1-10","article-title":"Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis","volume":"1","author":"Rafiyath","year":"2012","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.nano.2015.03.006_bb0125","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1128\/AAC.00235-13","article-title":"Efficacy and safety of liposomal clarithromycin and its effect on Pseudomonas aeruginosa virulence factors","volume":"57","author":"Alhajlan","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nano.2015.03.006_bb0130","doi-asserted-by":"crossref","first-page":"8741","DOI":"10.1016\/j.biomaterials.2010.07.082","article-title":"PLGA\/polymeric liposome for targeted drug and gene co-delivery","volume":"31","author":"Wang","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2015.03.006_bb0135","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jconrel.2010.10.017","article-title":"Trilysinoyl oleylamide-based cationic liposomes for systemic co-delivery of siRNA and an anticancer drug","volume":"155","author":"Shim","year":"2011","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2015.03.006_bb0140","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1038\/mtna.2013.30","article-title":"Tumor-targeted chlorotoxin-coupled nanoparticles for nucleic acid delivery to glioblastoma cells: a promising system for glioblastoma treatment","volume":"2","author":"Costa","year":"2013","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.nano.2015.03.006_bb0145","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1089\/hum.1993.4.6-781","article-title":"Safety and short-term toxicity of a novel cationic lipid formulation for human gene therapy","volume":"4","author":"San","year":"1993","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.nano.2015.03.006_bb0150","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/sj.gt.3300390","article-title":"Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis","volume":"4","author":"Porteous","year":"1997","journal-title":"Gene Ther"},{"key":"10.1016\/j.nano.2015.03.006_bb0155","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jconrel.2006.06.010","article-title":"In vitro and in vivo intracellular liposomal delivery of antisense oligonucleotides and anticancer drug","volume":"114","author":"Pakunlu","year":"2006","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2015.03.006_bb0160","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0166-3542(94)90039-6","article-title":"Cationic liposomes mediated delivery of antisense oligonucleotides targeted to HPV 16 E7 mRNA in CaSki cells","volume":"23","author":"Lappalainen","year":"1994","journal-title":"Antivir Res"},{"key":"10.1016\/j.nano.2015.03.006_bb0165","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.1158\/0008-5472.CAN-05-0530","article-title":"Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery","volume":"65","author":"Landen","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.nano.2015.03.006_bb0170","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jconrel.2011.11.034","article-title":"Novel cationic liposomes provide highly efficient delivery of DNA and RNA into dendritic cell progenitors and their immature offsets","volume":"160","author":"Markov","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2015.03.006_bb0175","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1038\/mtna.2013.22","article-title":"Efficient biodistribution and gene silencing in the lung epithelium via intravenous liposomal delivery of siRNA","volume":"2","author":"McCaskill","year":"2013","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.nano.2015.03.006_bb0180","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0168-3659(03)00295-5","article-title":"Controlled targeting of liposomal doxorubicin via the folate receptor in vitro","volume":"92","author":"Saul","year":"2003","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2015.03.006_bb0185","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0168-3659(01)00505-3","article-title":"Surface modification of liposomes for selective cell targeting in cardiovascular drug delivery","volume":"78","author":"Lestini","year":"2002","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2015.03.006_bb0190","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nmat3776","article-title":"Stimuli-responsive nanocarriers for drug delivery","volume":"12","author":"Mura","year":"2013","journal-title":"Nat Mater"},{"key":"10.1016\/j.nano.2015.03.006_bb0195","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1126\/science.364652","article-title":"Design of liposomes for enhanced local release of drugs by hyperthermia","volume":"202","author":"Yatvin","year":"1978","journal-title":"Science"},{"key":"10.1016\/j.nano.2015.03.006_bb0200","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1039\/c2ib20135f","article-title":"Stimulus-responsive nanopreparations for tumor targeting","volume":"5","author":"Zhu","year":"2013","journal-title":"Integr Biol (Camb)"},{"key":"10.1016\/j.nano.2015.03.006_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2014.08.015","article-title":"Stimuli-responsive nanomaterials for therapeutic protein delivery","volume":"194","author":"Lu","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2015.03.006_bb0210","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0169-409X(01)00243-5","article-title":"Pulsatile drug release control using hydrogels","volume":"54","author":"Kikuchi","year":"2002","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2015.03.006_bb0215","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jconrel.2006.07.007","article-title":"Molecular design of biodegradable polymeric micelles for temperature-responsive drug release","volume":"115","author":"Nakayama","year":"2006","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2015.03.006_bb0220","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1016\/j.biomaterials.2011.05.047","article-title":"Self-protecting core-shell magnetic nanoparticles for targeted, traceable, long half-life delivery of BCNU to gliomas","volume":"32","author":"Yang","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2015.03.006_bb0225","series-title":"Liposomes","first-page":"487","article-title":"Liposomal magnetofection","author":"Mykhaylyk","year":"2010"},{"key":"10.1016\/j.nano.2015.03.006_bb0230","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/sj.gt.3301624","article-title":"Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo","volume":"9","author":"Scherer","year":"2002","journal-title":"Gene Ther"},{"key":"10.1016\/j.nano.2015.03.006_bb0235","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/sj.gt.3302803","article-title":"Using magnetic forces to enhance non-viral gene transfer to airway epithelium in vivo","volume":"13","author":"Xenariou","year":"2006","journal-title":"Gene Ther"},{"key":"10.1016\/j.nano.2015.03.006_bb0240","first-page":"1065","article-title":"Targeted gene delivery to human osteosarcoma cells with magnetic cationic liposomes under a magnetic field","volume":"22","author":"Hirao","year":"2003","journal-title":"Int J Oncol"},{"key":"10.1016\/j.nano.2015.03.006_bb0245","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.bbrc.2011.06.019","article-title":"Tumor-targeting magnetic lipoplex delivery of short hairpin RNA suppresses IGF-1R overexpression of lung adenocarcinoma A549 cells in vitro and in vivo","volume":"410","author":"Wang","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nano.2015.03.006_bb0250","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nnano.2009.202","article-title":"A novel magnetic crystal-lipid nanostructure for magnetically guided in vivo gene delivery","volume":"4","author":"Namiki","year":"2009","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.nano.2015.03.006_bb0255","first-page":"324","article-title":"A novel approach for nucleic acid delivery into cancer cells","volume":"48","author":"Vainauska","year":"2012","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.nano.2015.03.006_bb0260","first-page":"306","article-title":"New device for enhancement of liposomal magnetofection efficiency of cancer cells","volume":"2011","author":"Baryshev","year":"2011","journal-title":"World Acad Sci Eng Technol"},{"key":"10.1016\/j.nano.2015.03.006_bb0265","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0306-4565(93)90013-J","article-title":"Mechanism of synergistic effects of cytokine and hyperthermia on cytotoxicity in HT-29 and MCF-7 cells: expression of MnSOD gene","volume":"18","author":"Lee","year":"1993","journal-title":"J Therm Biol"},{"key":"10.1016\/j.nano.2015.03.006_bb0270","first-page":"101","article-title":"Enhancement of MuIFN-gamma antitumor effects by hyperthermia: sequence dependence and time dependence of hyperthermia","volume":"8","author":"Fleischmann","year":"1994","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1016\/j.nano.2015.03.006_bb0275","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0304-3835(99)00038-5","article-title":"Synergism between mild hyperthermia and interferon-\u03b2 gene expression","volume":"139","author":"Bouhon","year":"1999","journal-title":"Cancer Lett"},{"key":"10.1016\/j.nano.2015.03.006_bb0280","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1016\/j.ejca.2008.07.038","article-title":"Hyperthermia adds to chemotherapy","volume":"44","author":"Issels","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.nano.2015.03.006_bb0285","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1245\/ASO.2003.08.006","article-title":"Thermal enhancement of new chemotherapeutic agents at moderate hyperthermia","volume":"10","author":"Mohamed","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.nano.2015.03.006_bb0290","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/wnan.1176","article-title":"Phase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancer","volume":"4","author":"Rapoport","year":"2012","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"10.1016\/j.nano.2015.03.006_bb0295","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1021\/js950407f","article-title":"Development of inherently echogenic liposomes as an ultrasonic contrast agent","volume":"85","author":"Alkan-Onyuksel","year":"1996","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nano.2015.03.006_bb0300","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1002\/jps.1142","article-title":"Improving ultrasound reflectivity and stability of echogenic liposomal dispersions for use as targeted ultrasound contrast agents","volume":"90","author":"Huang","year":"2001","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nano.2015.03.006_bb0305","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0301-5629(01)00512-9","article-title":"Physical correlates of the ultrasonic reflectivity of lipid dispersions suitable as diagnostic contrast agents","volume":"28","author":"Huang","year":"2002","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.nano.2015.03.006_bb0310","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/jps.21173","article-title":"Echogenic liposome compositions for increased retention of ultrasound reflectivity at physiologic temperature","volume":"97","author":"Buchanan","year":"2008","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nano.2015.03.006_bb0315","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1016\/j.ymthe.2006.08.625","article-title":"553. Development of echo-contrast gas entrapping liposome as gene and siRNA delivery tool","volume":"13","author":"Negishi","year":"2006","journal-title":"Mol Ther"},{"key":"10.1016\/j.nano.2015.03.006_bb0320","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.addr.2008.03.002","article-title":"Driving delivery vehicles with ultrasound","volume":"60","author":"Ferrara","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2015.03.006_bb0325","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.addr.2014.01.009","article-title":"Nucleic acid delivery with microbubbles and ultrasound","volume":"72","author":"Rychak","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2015.03.006_bb0330","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1464-410X.2008.07775.x","article-title":"The feasibility and safety of high-intensity focused ultrasound as salvage therapy for recurrent prostate cancer following external beam radiotherapy","volume":"102","author":"Zacharakis","year":"2008","journal-title":"Int Br J Urol"},{"key":"10.1016\/j.nano.2015.03.006_bb0335","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1021\/la0631668","article-title":"Controlling liposomal drug release with low frequency ultrasound: mechanism and feasibility","volume":"23","author":"Schroeder","year":"2007","journal-title":"Langmuir"},{"key":"10.1016\/j.nano.2015.03.006_bb0340","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jconrel.2012.08.019","article-title":"Rapid skin permeabilization by the simultaneous application of dual-frequency, high-intensity ultrasound","volume":"163","author":"Schroeder","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2015.03.006_bb0345","doi-asserted-by":"crossref","first-page":"7813","DOI":"10.1016\/j.biomaterials.2010.06.058","article-title":"Development of an ultrasound-responsive and mannose-modified gene carrier for DNA vaccine therapy","volume":"31","author":"Un","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2015.03.006_bb0350","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1038\/srep02242","article-title":"Ultrasound-enhanced delivery of Morpholino with Bubble liposomes ameliorates the myotonia of myotonic dystrophy model mice","volume":"3","author":"Koebis","year":"2013","journal-title":"Sci Rep"},{"key":"10.1016\/j.nano.2015.03.006_bb0355","first-page":"4","article-title":"Systemic delivery of miR-126 by miRNA-loaded Bubble liposomes for the treatment of hindlimb ischemia","author":"Endo-Takahashi","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.nano.2015.03.006_bb0360","doi-asserted-by":"crossref","first-page":"5932","DOI":"10.1016\/j.biomaterials.2014.03.072","article-title":"Tumor-penetrating codelivery of siRNA and paclitaxel with ultrasound-responsive nanobubbles hetero-assembled from polymeric micelles and liposomes","volume":"35","author":"Yin","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2015.03.006_bb0365","first-page":"1621","article-title":"Potential and problems in ultrasound-responsive drug delivery systems","volume":"8","author":"Zhao","year":"2013","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2015.03.006_bb0370","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1517\/14712598.5.1.23","article-title":"Smart polymeric carriers for enhanced intracellular delivery of therapeutic macromolecules","volume":"5","author":"El-Sayed","year":"2005","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.nano.2015.03.006_bb0375","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jconrel.2007.12.017","article-title":"A review of stimuli-responsive nanocarriers for drug and gene delivery","volume":"126","author":"Ganta","year":"2008","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2015.03.006_bb0380","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0169-409X(02)00179-5","article-title":"Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities","volume":"55","author":"Saito","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2015.03.006_bb0385","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2217\/nnm.13.118","article-title":"Current trends in the use of liposomes for tumor targeting","volume":"8","author":"Deshpande","year":"2013","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.nano.2015.03.006_bb0390","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0304-3940(99)00856-3","article-title":"Enhanced transgene expression in rat brain cell cultures with a disulfide-containing cationic lipid","volume":"277","author":"Ajmani","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.nano.2015.03.006_bb0395","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1074-5521(00)00030-2","article-title":"Lipoic acid-derived amphiphiles for redox-controlled DNA delivery","volume":"7","author":"Balakirev","year":"2000","journal-title":"Chem Biol"},{"key":"10.1016\/j.nano.2015.03.006_bb0400","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/adhm.201400039","article-title":"Enhanced intracellular siRNA delivery using bioreducible lipid-like nanoparticles","volume":"3","author":"Wang","year":"2014","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.nano.2015.03.006_bb0405","article-title":"Bioreducible liposomes for gene delivery: from the formulation to the mechanism of action","volume":"5","author":"Gabriele","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2015.03.006_bb0410","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.ejpb.2014.08.005","article-title":"pH-sensitive stearoyl-PEG-poly(methacryloyl sulfadimethoxine) decorated liposomes for the delivery of gemcitabine to cancer cells","volume":"88","author":"Bersani","year":"2014","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"10.1016\/j.nano.2015.03.006_bb0415","first-page":"145","article-title":"Recent advances with liposomes as pharmaceutical carriers","volume":"4","author":"Torchilin","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.nano.2015.03.006_bb0420","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ajps.2013.11.002","article-title":"Formation strategies, mechanism of intracellular delivery and potential clinical applications of pH-sensitive liposomes","volume":"8","author":"Liu","year":"2013","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.nano.2015.03.006_bb0425","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0006-291X(92)90565-3","article-title":"Oligonucleotides encapsulated in pH sensitive liposomes are efficient toward Friend retrovirus","volume":"183","author":"Ropert","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nano.2015.03.006_bb0430","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0022-3565(24)29642-7","article-title":"In vivo delivery of antisense oligonucleotides in pH-sensitive liposomes inhibits lipopolysaccharide-induced production of tumor necrosis factor-alpha in rats","volume":"297","author":"Ponnappa","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.nano.2015.03.006_bb0435","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jconrel.2012.09.009","article-title":"A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo","volume":"163","author":"Sato","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2015.03.006_bb0440","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jconrel.2013.10.003","article-title":"RNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system","volume":"173","author":"Sakurai","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2015.03.006_bb0445","doi-asserted-by":"crossref","first-page":"e92924","DOI":"10.1371\/journal.pone.0092924","article-title":"Co-delivery of doxorubicin and SATB1 shRNA by thermosensitive magnetic cationic liposomes for gastric cancer therapy","volume":"9","author":"Zhao","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2015.03.006_bb0450","doi-asserted-by":"crossref","unstructured":"Ta T and Porter TM. Thermosensitive liposomes for localized delivery and triggered release of chemotherapy. Journal of Controlled Release. 169: 112\u2013125.","DOI":"10.1016\/j.jconrel.2013.03.036"},{"key":"10.1016\/j.nano.2015.03.006_bb0455","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1023\/A:1007930925862","article-title":"Enhancement of cytokine expression in transiently transfected cells by magnetoliposome mediated hyperthermia","volume":"25","author":"Bouhon","year":"1997","journal-title":"Cytotechnology"},{"key":"10.1016\/j.nano.2015.03.006_bb0460","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1002\/adma.201101086","article-title":"Protection and promotion of UV radiation-induced liposome leakage via DNA-directed assembly with gold nanoparticles","volume":"23","author":"Dave","year":"2011","journal-title":"Adv Mater"},{"key":"10.1016\/j.nano.2015.03.006_bb0465","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1016\/j.biomaterials.2012.12.051","article-title":"Enzyme-responsive liposomes modified adenoviral vectors for enhanced tumor cell transduction and reduced immunogenicity","volume":"34","author":"Wan","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2015.03.006_bb0470","doi-asserted-by":"crossref","first-page":"494011","DOI":"10.1088\/0957-4484\/22\/49\/494011","article-title":"Stimuli-responsive releasing of gold nanoparticles and liposomes from aptamer-functionalized hydrogels","volume":"22","author":"El-Hamed","year":"2011","journal-title":"Nanotechnology"},{"key":"10.1016\/j.nano.2015.03.006_bb0475","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1002\/ange.201400268","article-title":"Enhanced anticancer efficacy by ATP-mediated liposomal drug delivery","volume":"126","author":"Mo","year":"2014","journal-title":"Angew Chem"},{"key":"10.1016\/j.nano.2015.03.006_bb0485","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2217\/nnm.10.50","article-title":"Stimulus-responsive macromolecules and nanoparticles for cancer drug delivery","volume":"5","author":"MacEwan","year":"2010","journal-title":"Nanomedicine (Lond)"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963415000805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963415000805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T22:40:55Z","timestamp":1747867255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963415000805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":96,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1549963415000805"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2015.03.006","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stimuli-responsive liposomes for the delivery of nucleic acid therapeutics","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2015.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}